Cargando…
Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study
This prospective study aimed to evaluate the efficacy and safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma (HCC). The patients with intermediate/advanced HCC, who met predetermined inclusion and exclusion criteria, underwent oral treatment of apatinib 500 mg daily....
Autores principales: | Yu, Wen-Chang, Zhang, Kong-Zhi, Chen, Shi-Guang, Liu, Wei-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779795/ https://www.ncbi.nlm.nih.gov/pubmed/29505026 http://dx.doi.org/10.1097/MD.0000000000009704 |
Ejemplares similares
-
Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report
por: Zhao, Chunbo, et al.
Publicado: (2017) -
Safety and efficacy of INTRABEAM intraoperative radiotherapy for invasive thymoma
por: Cui, Tian-xiang, et al.
Publicado: (2020) -
Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study
por: Wang, Yizhuo, et al.
Publicado: (2018) -
The value of contrast-enhanced ultrasound in predicting postoperative recurrence of hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Fu, Jieying, et al.
Publicado: (2021) -
Value of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinoma
por: Huang, Ya-Qin, et al.
Publicado: (2016)